UCC licensed innovative device that moves organs during surgery to Skellig Surgical
SecuRetract, Skellig Surgical鈥檚 first commercial product, has been licensed by UCC. Designed to manipulate organs that obscure and limit the ability to perform keyhole surgery, SecuRetract is UCC鈥檚 latest foray into medtech. Through a new licensing agreement, it is now on the market.
Skellig Surgical participated in GatewayUCC鈥檚 Sprint Programme. They are now residents of GatewayUCC and have 4 employees. The company is an Enterprise Ireland HPSU.
Developed through the work of dozens of surgeons over four years of research, the prize-winning device uses clever engineering to improve the surgical process. Inflated inside the 5mm surgical incision used in laparoscopic surgery, the device keeps the bowels from obstructing surgeons鈥� views.
鈥淲e are proud to have taken this early idea right through to the realisation of a product,鈥� said Conor O鈥橲hea, co-founder and CEO of Skellig Surgical. O鈥橲hea, who worked with his PhD supervisor and fellow co-founder, Dr. P谩draig Cantillon-Murphy, to get the device developed, claims it improves patient safety. The clinical utility and design of SecuRetract has been recognised with multiple awards, including the Royal Academy of Medicine in Ireland David Boucher-Hayes Medal for Innovation in Surgery.
_1.jpg "UCC licensed innovative device that moves organs during surgery to Skellig Surgical")
GatewayUCC
GatewayUCC - Gorlann Ghnó
Contact us
C/O Office of Technology Transfer, Western Gateway Building, Western Road, Cork, Ireland.,